SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline QUAD Q1 2026 Earnings EPS Beats Estimates on Strong Cost Management CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick EDAP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Operational Headwinds